US 9090895
Compositions and methods for inhibiting expression of the HAMP gene
granted A61PA61P43/00A61P7/06
Quick answer
US patent 9090895 (Compositions and methods for inhibiting expression of the HAMP gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P43/00, A61P7/06